<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Management decisions for thromboprophylaxis in <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> need to balance the risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> against serious <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The objective of the present analysis is to compare the <z:hpo ids='HP_0000822'>Hypertension</z:hpo>, Abnormal renal/liver function, <z:hpo ids='HP_0001297'>Stroke</z:hpo>, <z:mp ids='MP_0001914'>Bleeding</z:mp> history or predisposition, Labile international normalized ratio, Elderly (&gt;65 years), Drugs/alcohol concomitantly (HAS-BLED) score against other older <z:mp ids='MP_0001914'>bleeding</z:mp> risk scores and the new Anticoagulation and Risk Factors in <z:hpo ids='HP_0005110'>Atrial Fibrillation</z:hpo> score in an <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> cohort </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: Patients diagnosed with nonvalvular <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> in a 4-hospital institution between 2000 and 2010 were identified </plain></SENT>
<SENT sid="3" pm="."><plain>Independent risk factors of <z:mp ids='MP_0001914'>bleeding</z:mp> were investigated using Cox regression </plain></SENT>
<SENT sid="4" pm="."><plain>The predictive value of several <z:mp ids='MP_0001914'>bleeding</z:mp> risk schema was assessed using the c-statistic and net reclassification improvement </plain></SENT>
<SENT sid="5" pm="."><plain>Oral anticoagulation use was highest in moderate-risk patients (59.8%) but only slightly more than high-risk (50.1%) and low-risk (46.4%) patients </plain></SENT>
<SENT sid="6" pm="."><plain>Those at higher <z:mp ids='MP_0001914'>bleeding</z:mp> risk (HAS-BLED ≥ 3) were also at highest risk of <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0001907'>thromboembolism</z:hpo> or <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0001907'>thromboembolism</z:hpo>/<z:hpo ids='HP_0011420'>death</z:hpo>, as well as <z:mp ids='MP_0001914'>bleeding</z:mp> and <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality </plain></SENT>
<SENT sid="7" pm="."><plain>On multivariable analysis, independent predictors of <z:mp ids='MP_0001914'>bleeding</z:mp> were age ≥ 75 years and age ≥ 65 years, alcohol excess, <z:hpo ids='HP_0001903'>anemia</z:hpo>, and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> risk scores had only modest predictive ability for <z:mp ids='MP_0001914'>bleeding</z:mp>, whether on <z:chebi fb="6" ids="28384">vitamin K</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi> or not (c-statistic ≈0.6) </plain></SENT>
<SENT sid="9" pm="."><plain>When the HAS-BLED score was compared with other <z:mp ids='MP_0001914'>bleeding</z:mp> risk scores, the net reclassification improvement was significantly improved against <z:hpo ids='HP_0000001'>all</z:hpo> other scores tested </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Current oral anticoagulation prescribing patterns would suggest that <z:mp ids='MP_0001914'>bleeding</z:mp> risk estimation by clinicians is poor and that oral anticoagulation prescribing does not reflect <z:mp ids='MP_0001914'>bleeding</z:mp> risk per se </plain></SENT>
<SENT sid="11" pm="."><plain>The HAS-BLED score performs well in relation to predicting <z:mp ids='MP_0001914'>bleeding</z:mp> events compared with older <z:mp ids='MP_0001914'>bleeding</z:mp> scores and the Anticoagulation and Risk Factors in <z:hpo ids='HP_0005110'>Atrial Fibrillation</z:hpo> score, with significantly improved reclassification using HAS-BLED compared with <z:hpo ids='HP_0000001'>all</z:hpo> other <z:mp ids='MP_0001914'>bleeding</z:mp> risk scores tested </plain></SENT>
</text></document>